The Miami Entrepreneur

Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill 

Read Time:9 Second

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish pharmaceutical giant’s blockbuster drugs Ozempic and Wegovy.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Home-price growth loses more steam in July, Case Shiller says, but still inches up to new record high
Next post Fed’s Bowman says inflation remains a concern despite recent progress